Kissei Pharmaceutical Co., Ltd. (TYO:4547)
3,620.00
-45.00 (-1.23%)
Mar 11, 2025, 3:30 PM JST
Kissei Pharmaceutical Revenue
Kissei Pharmaceutical had revenue of 23.20B JPY in the quarter ending December 31, 2024, with 11.12% growth. This brings the company's revenue in the last twelve months to 83.39B, up 13.12% year-over-year. In the fiscal year ending March 31, 2024, Kissei Pharmaceutical had annual revenue of 75.58B with 11.98% growth.
Revenue (ttm)
83.39B
Revenue Growth
+13.12%
P/S Ratio
1.99
Revenue / Employee
46.87M
Employees
1,779
Market Cap
161.16B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 75.58B | 8.09B | 11.98% |
Mar 31, 2023 | 67.49B | 2.11B | 3.23% |
Mar 31, 2022 | 65.38B | -3.66B | -5.31% |
Mar 31, 2021 | 69.04B | 5.81B | 9.19% |
Mar 31, 2020 | 63.23B | -9.06B | -12.54% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 837.44B |
Otsuka Holdings | 2,329.86B |
Terumo | 1,011.15B |
Astellas Pharma | 1,867.63B |
Olympus | 993.33B |